KRONOX LAB SCIENCES
|
KRONOX LAB SCIENCES Last 5 Year Financial Ratios History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|
Operational & Financial Ratios | ||||
Earnings Per Share (Rs) | 5.75 | 4.42 | 565.44 | 403.73 |
CEPS(Rs) | 6.10 | 4.82 | 4.01 | 3.00 |
DPS(Rs) | 0.50 | - | - | - |
Book NAV/Share(Rs) | 17.87 | 12.06 | 1,674.40 | 1,112.61 |
Tax Rate(%) | 25.37 | 25.58 | 25.76 | 26.40 |
Margin Ratios | ||||
Core EBITDA Margin(%) | 31.51 | 22.72 | 23.95 | 23.70 |
EBIT Margin(%) | 31.84 | 23.16 | 22.81 | 21.78 |
Pre Tax Margin(%) | 31.84 | 23.06 | 22.32 | 21.17 |
PAT Margin (%) | 23.76 | 17.16 | 16.57 | 15.58 |
Cash Profit Margin (%) | 25.19 | 18.73 | 19.04 | 18.74 |
Performance Ratios | ||||
ROA(%) | 33.54 | 29.78 | 29.03 | 26.01 |
ROE(%) | 38.45 | 38.55 | 40.58 | 36.29 |
ROCE(%) | 51.52 | 51.63 | 55.32 | 50.71 |
Asset Turnover(x) | 1.41 | 1.74 | 1.75 | 1.67 |
Sales/Fixed Asset(x) | 2.85 | 4.03 | 4.17 | 3.53 |
Working Capital/Sales(x) | 2.31 | 3.77 | 2.71 | 3.42 |
Efficiency Ratios | ||||
Fixed Capital/Sales(x) | 0.35 | 0.25 | 0.24 | 0.28 |
Receivable days | 73.51 | 84.69 | 91.52 | 90.24 |
Inventory Days | 37.42 | 31.86 | 28.85 | 32.11 |
Payable days | 55.93 | 64.28 | 69.59 | 69.52 |
Valuation Parameters | ||||
PER(x) | - | - | - | - |
PCE(x) | - | - | - | - |
Price/Book(x) | - | - | - | - |
Yield(%) | - | - | - | - |
EV/Net Sales(x) | 0.37 | 0.35 | -0.02 | -0.03 |
EV/Core EBITDA(x) | 1.12 | 1.42 | -0.09 | -0.12 |
EV/EBIT(x) | 1.17 | 1.52 | -0.10 | -0.13 |
EV/CE(x) | 0.50 | 0.75 | -0.05 | -0.07 |
M Cap / Sales | - | - | - | - |
Growth Ratio | ||||
Net Sales Growth(%) | -5.98 | 16.21 | 31.68 | - |
Core EBITDA Growth(%) | 26.52 | 13.67 | 33.44 | - |
EBIT Growth(%) | 29.25 | 17.99 | 37.91 | - |
PAT Growth(%) | 30.17 | 20.37 | 40.05 | - |
EPS Growth(%) | 30.16 | -99.22 | 40.05 | - |
Financial Stability Ratios | ||||
Total Debt/Equity(x) | - | - | 0.02 | - |
Current Ratio(x) | 6.07 | 3.89 | 3.21 | 3.30 |
Quick Ratio(x) | 4.87 | 2.84 | 2.66 | 2.61 |
Interest Cover(x) | - | 237.24 | 46.32 | 35.61 |
Total Debt/Mcap(x) | - | - | - | - |
Compare Financial Ratios of peers of KRONOX LAB SCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KRONOX LAB SCIENCES | ₹555.0 Cr | 0.5% | -2.5% | NA | Stock Analytics | |
PIDILITE INDUSTRIES | ₹155,977.0 Cr | 1.4% | 12.3% | 5.5% | Stock Analytics | |
SOLAR INDUSTRIES INDIA | ₹118,372.0 Cr | 7.9% | 27.1% | 50.8% | Stock Analytics | |
SRF | ₹88,980.8 Cr | 0.3% | NA | 19% | Stock Analytics | |
GUJARAT FLUOROCHEMICALS | ₹43,549.5 Cr | 0.8% | 3.4% | 10.2% | Stock Analytics | |
GODREJ INDUSTRIES | ₹39,268.7 Cr | 2.8% | -0.1% | 40.3% | Stock Analytics |
KRONOX LAB SCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KRONOX LAB SCIENCES | 0.5% |
-2.5% |
|
SENSEX | 4.4% |
6.4% |
9.8% |
You may also like the below Video Courses